Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,328.40
(
-0.91%
)
Dow Jones
49,141.93
(
-0.34%
)
Brent Oil
104.27
(
2.11%
)
Bitcoin
76,455.16
(
-1.18%
)
News Focus
News Focus
Post# of 257458
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122897
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 252765

Thursday, 08/01/2024 4:09:59 PM

Thursday, August 01, 2024 4:09:59 PM

Post# of 257458

…it reinforces the notion that the mRNA platform may not be ideal for vaccines intended for long duration like HSV…

I understand why mRNA’s quick-reformulation feature is superfluous for slow-mutating or non-mutating viruses, but I do not see why this necessarily makes mRNA technology inferior for such applications.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today